Farmacias Benavides, S.A.B. de C.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
July 28, 2023 at 08:55 am EDT
Share
Farmacias Benavides, S.A.B. de C.V. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was MXN 4,251.63 million compared to MXN 3,919.81 million a year ago. Net income was MXN 91.15 million compared to net loss of MXN 26.17 million a year ago. Basic earnings per share from continuing operations was MXN 0.22295 compared to basic loss per share from continuing operations of MXN 0.063997 a year ago.
For the six months, sales was MXN 8,525.18 million compared to MXN 7,855.33 million a year ago. Net income was MXN 175.69 million compared to MXN 55.87 million a year ago. Basic earnings per share from continuing operations was MXN 0.429721 compared to MXN 0.136661 a year ago.
Farmacias Benavides SAB de CV is a Mexico-based company primarily engaged in the pharmaceutical and chemical industry. The Company operates a network of over 700 drug stores located nationwide under the Farmacias Benavides name. Through its network of drug stores, it sells a variety prescription and over the counter (OTC) medicines, cosmetics, personal and baby care products and toiletries, as well as it also provides such related services as laboratory samples, home delivery, prescription laboratory, online pharmacy and photo processing services. As of December 31, 2011, the Company owned such subsidiaries as Servicios Operacionales Benavides SA de CV, Benavides de Reynosa SA de CV and Servicios Logisticos Benavides SA de CV, and Fasa Investment Limitada which was its majority shareholder with 85.25% of its interest.
FARMACIAS BENAVIDES, S.A.B. DE C.V. 
